Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Mentioning method of administration + brand name in a subject line/preview text where balance cannot be included.
-
What are the guidelines around saying method of admin with the brand name in a subject line/preview text of an email. For example, I understand that if we say "injection" with the brand name in the SL/PT that we need to include balance which we can't but how come for brands where their official brand name is "[brand name] I.V" that we can use that in a SL/PT without needing balance?
-
Generally, when the route of administration is presented as a claim of product merit (e.g. promotional claims such as “convenient oral tablet” or “subcutaneous injection for at-home use”) in an email envelope (i.e. subject line/preview text), it requires fair balance (FB). Please see our "Tips and checklist" document. This principle applies regardless of the dosage form appearing in the proprietary/non-proprietary name (e.g. “PrDrug X (examplumab for IV injection)”.
